23375-15-7

Upstream product

• 100-01-6 4-nitro-aniline 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 106-50-3 1,4-phenylenediamine 
• 23383-95-1 1,1,1-trifluoro-N-(4-nitrophenyl)methanesulfonamide 

Downstream Products

• 57946-46-0 (4-Trifluoromethanesulfonylamino-phenylamino)-acetic acid ethyl ester 
• 1187212-57-2 C,C,C-trifluoro-N-(4-(4-oxo-4,5-dihydrothiazol-2-ylamino)phenyl)methanesulfonamide 
• 1187210-22-5 C,C,C-trifluoro-N-(4-(5-(4-(4-fluorobenzyloxy)benzylidene)-4-oxo-4,5-dihydrothiazol-2-ylamino)phenyl)methanesulfonamide 
• 1187210-24-7 C,C,C-trifluoro-N-(4-(5-(4-(4-methylbenzyloxy)benzylidene)-4-oxo-4,5-dihydrothiazol-2-ylamino)phenyl)methanesulfonamide 

Relevant academic research and scientific papers

BIFUNCTIONAL COMPOUNDS AND USE FOR REDUCING URIC ACID LEVELS

Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing uric acid levels

NOVEL PROTEIN TYROSINE PHOSPHATASE - IB INHIBITORS

The present invention relates to the novel compounds of the general formula (I), wherein the symbols are same as described in specification, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, to process and intermediates for the preparation of the above said compounds, having the utility of these compounds in medicine and to methods for their therapeutic use, and their use in the treatment of metabolic disorders.